FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Vanta Bioscience IPO.
March 21, 2024 1:36:00 AM
The price of the IPO will benefit Reddit�s largest shareholders, including co-founder Steve Huffman�who has a 3.3% stake in the company, according to the New York Times�Conde Nast�s parent ...
Published by : ForbesMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 2, 2024 1:15:00 PM
Private equity firm Silver Lake is acquiring all outstanding shares, stockholders will receive $27.50 per share, and will value the owner of WME at $13 billion. By Erik Hayden Executive Editor ...
Published by : The Hollywood ReporterMarch 21, 2024 3:43:00 AM
Social media platform Reddit, priced its initial public offering at the top of its targeted range of $31 to $34 per share on Wednesday, raising $748 million and giving the ailing technology IPO ...
Published by : New York PostMarch 21, 2024 8:52:00 PM
The reception is a positive indicator for the social media sector, which has been experiencing an IPO dry spell. Founded in 2005 by web developer Steve Huffman and entrepreneur Alexis Ohanian ...
Published by : Fox BusinessMarch 23, 2024 6:40:00 AM
Shares of the social media company soared on its Big Board debut under the ticker RDDT, closing at $50.44, or 48 percent above its IPO price. This brought its fully diluted market capitalization ...
Published by : Ars TechnicaMarch 21, 2024 11:41:00 PM
Shares of social forum giant Reddit closed its first day of trading at $50.31, up nearly 48% from its IPO price of $34 per share. The company had indicated a target range of $31 to $34 per share ...
Published by : TechCrunchApril 18, 2024 3:30:00 AM
IIFL Securities and ICICI Securities are the book running lead managers for the JNK India IPO, while Link Intime India is the registrar for the issue. Nephro Care IPO: Nephro Care India Ltd has ...
Published by : Business TodayMarch 21, 2024 3:30:00 AM
The stock climbed as high as $57.80 in afternoon trading before closing at $50.44, a jump of 48% from the IPO price. That strong performance signals that Reddit�s plan to expand its nascent ...
Published by : MorningstarVanta Bioscience IPO Listing Date
› Listing Date: Friday, October 6, 2017
› BSE Script Code: 540729
› Listing In: ‘M’ Group of Securities
› ISIN: INE695X01011
› Issue Price: Rs 50 Per Equity Share
› Face Value: Rs 10 Per Equity Share
The issue of Vanta Bioscience Ltd opens on Sep 25, 2017 and closes for subscription on Sep 27, 2017. The equity shares of the company to be list at BSE SME. The price band for the issue has been fixed at Rs 50.
Vanta Bioscience Ltd is entering in the capital market with an IPO of 1,512,000 Equity Shares of Rs 10 aggregating up to Rs 7.56 Cr. The price band for the issue has been fixed at Rs 50.
Vanta Bioscience Ltd (VBL) is a preclinical contract research company whhich offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
The issue opens on Sep 25, 2017 and closes for subscription on Sep 27, 2017. The equity shares of the company to be list at BSE SME platform.
The Vanta Bioscience IPO is proposed to open on September 25, 2017. The IPO application ends on September 27, 2017.
Retail investors can apply in the retail or non-institutional investor category from September 25, 2017 to September 27, 2017. The Vanta Bioscience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Vanta Bioscience IPO will open for subscription on September 25, 2017. The public issue will close on September 27, 2017.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|